Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genetic analysis of an orbital metastasis from a primary hepatic neuroendocrine carcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Genetic profiles distinguish different types of hereditary ovarian cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Rational targeting of population groups and residential areas for colorectal cancer screening

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Function, information, and contributions: An evaluation of national multidisciplinary team meetings for rare cancers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Kristina Lagerstedt-Robinson
  • Anna Rohlin
  • Christos Aravidis
  • Beatrice Melin
  • Margareta Nordling
  • Marie Stenmark-Askmalm
  • Annika Lindblom
  • Mef Nilbert
Vis graf over relationer

Lynch syndrome caused by constitutional mismatch‑repair defects is one of the most common hereditary cancer syndromes with a high risk for colorectal, endometrial, ovarian and urothelial cancer. Lynch syndrome is caused by mutations in the mismatch repair (MMR) genes i.e., MLH1, MSH2, MSH6 and PMS2. After 20 years of genetic counseling and genetic testing for Lynch syndrome, we have compiled the mutation spectrum in Sweden with the aim to provide a population-based perspective on the contribution from the different MMR genes, the various types of mutations and the influence from founder mutations. Mutation data were collected on a national basis from all laboratories involved in genetic testing. Mutation analyses were performed using mainly Sanger sequencing and multiplex ligation-dependent probe amplification. A total of 201 unique disease-predisposing MMR gene mutations were identified in 369 Lynch syndrome families. These mutations affected MLH1 in 40%, MSH2 in 36%, MSH6 in 18% and PMS2 in 6% of the families. A large variety of mutations were identified with splice site mutations being the most common mutation type in MLH1 and frameshift mutations predominating in MSH2 and MSH6. Large deletions of one or several exons accounted for 21% of the mutations in MLH1 and MSH2 and 22% in PMS2, but were rare (4%) in MSH6. In 66% of the Lynch syndrome families the variants identified were private and the effect from founder mutations was limited and predominantly related to a Finnish founder mutation that accounted for 15% of the families with mutations in MLH1. In conclusion, the Swedish Lynch syndrome mutation spectrum is diverse with private MMR gene mutations in two-thirds of the families, has a significant contribution from internationally recognized mutations and a limited effect from founder mutations.

OriginalsprogEngelsk
TidsskriftOncology Reports
Vol/bind36
Udgave nummer5
Sider (fra-til)2823-2835
Antal sider13
ISSN1021-335X
DOI
StatusUdgivet - nov. 2016

ID: 49798403